Despite no prognosis difference in OS analysis, the bioinformatic analysis revealed that the lower ATP7A expressed CRC patients may have a better clinical prognosis in DFS (Supplementary Figure 2B, P<0.05). The gene discussed is ATP7A; the disease is colorectal carcinoma.